| Trial of solanezumab for mild dementia due to Alzheimer’s disease LS Honig, B Vellas, M Woodward, M Boada, R Bullock, M Borrie, K Hager, ... New England Journal of Medicine 378 (4), 321-330, 2018 | 963 | 2018 |
| Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease A Maczurek, K Hager, M Kenklies, M Sharman, R Martins, J Engel, ... Advanced drug delivery reviews 60 (13-14), 1463-1470, 2008 | 427 | 2008 |
| Lipoic acid as a novel treatment for Alzheimer's disease and related dementias L Holmquist, G Stuchbury, K Berbaum, S Muscat, S Young, K Hager, ... Pharmacology & therapeutics 113 (1), 154-164, 2007 | 393 | 2007 |
| Alpha-lipoic acid as a new treatment option for Azheimer type dementia K Hager, A Marahrens, M Kenklies, P Riederer, G Münch Archives of gerontology and geriatrics 32 (3), 275-282, 2001 | 283 | 2001 |
| Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment N Ahmed, U Ahmed, PJ Thornalley, K Hager, G Fleischer, G Münch Journal of neurochemistry 92 (2), 255-263, 2005 | 281 | 2005 |
| α-Lipoic acid as a new treatment option for Alzheimer’s disease—A 48 months follow-up analysis K Hager, M Kenklies, J McAfoose, J Engel, G Münch Neuropsychiatric disorders an integrative approach, 189-193, 2007 | 251 | 2007 |
| Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease H Jiang, E Schiffer, Z Song, J Wang, P Zürbig, K Thedieck, S Moes, ... Proceedings of the National Academy of Sciences 105 (32), 11299-11304, 2008 | 205 | 2008 |
| Interleukin-6 and selected plasma proteins in healthy persons of different ages K Hager, U Machein, S Krieger, D Platt, G Seefried, J Bauer Neurobiology of aging 15 (6), 771-772, 1994 | 199 | 1994 |
| A multinational, randomised, 12‐week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease RW Jones, H Soininen, K Hager, D Aarsland, P Passmore, A Murthy, ... International journal of geriatric psychiatry 19 (1), 58-67, 2004 | 155 | 2004 |
| Fibrin degeneration product concentrations (D-dimers) in the course of ageing K Hager, D Platt Gerontology 41 (3), 159-165, 1995 | 154 | 1995 |
| Living with and dying from advanced heart failure: understanding the needs of older patients at the end of life K Klindtworth, P Oster, K Hager, O Krause, J Bleidorn, N Schneider BMC geriatrics 15, 1-11, 2015 | 152 | 2015 |
| Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer’s disease K Hager, AS Baseman, JS Nye, HR Brashear, J Han, M Sano, B Davis, ... Neuropsychiatric disease and treatment, 391-401, 2014 | 113 | 2014 |
| Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease H Selle, J Lamerz, K Buerger, A Dessauer, K Hager, H Hampel, J Karl, ... Combinatorial chemistry & high throughput screening 8 (8), 801-806, 2005 | 83 | 2005 |
| Blood coagulation factors in the elderly K Hager, J Setzer, T Vogl, J Voit, D Platt Archives of gerontology and geriatrics 9 (3), 277-282, 1989 | 80 | 1989 |
| Fibrinogen and aging K Hager, M Felicetti, G Seefried, D Platt Aging Clinical and Experimental Research 6, 133-138, 1994 | 73 | 1994 |
| An accurate fully automated panel of plasma biomarkers for Alzheimer's disease S Palmqvist, E Stomrud, N Cullen, S Janelidze, E Manuilova, A Jethwa, ... Alzheimer's & Dementia 19 (4), 1204-1215, 2023 | 64 | 2023 |
| ‘Who is going to explain it to me so that I understand?’Health care needs and experiences of older patients with advanced heart failure MG Gerlich, K Klindtworth, P Oster, M Pfisterer, K Hager, N Schneider European journal of ageing 9 (4), 297-303, 2012 | 34 | 2012 |
| An observational clinical study of the efficacy and tolerability of donepezil in the treatment of Alzheimer’s disease K Hager, P Calabrese, L Frölich, C Göbel, FM Berger Dementia and geriatric cognitive disorders 15 (4), 189-198, 2003 | 27 | 2003 |
| Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo … K Hager, AS Baseman, JS Nye, HR Brashear, J Han, M Sano, B Davis, ... Alzheimer's Research & Therapy 8, 1-10, 2016 | 25 | 2016 |
| Studien der Krankheitsverarbeitung nach einem Schlaganfall K Hager, K Ziegler Zeitschrift für Gerontologie und Geriatrie 31, 9-15, 1998 | 22 | 1998 |
